Supplementary Table 3. Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 3. Demographics, Disease Characteristics, and Medical History at Baseline for Patients Enrolled in EAMS Who Consented to EQ-5D-3L Completion and Returned a Questionnaire
创建时间：
2021-06-08
